cobalt has been researched along with Hyperoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lapatto, R; Linder, N; Martelin, E; Raivio, KO | 1 |
| Gittes, GK; Greenwald, JA; Longaker, MT; Mehrara, BJ; Saadeh, PB; Spector, JA; Steinbrech, DS | 1 |
2 other study(ies) available for cobalt and Hyperoxia
| Article | Year |
|---|---|
Posttranslational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions.
Topics: Cell Hypoxia; Cell Line, Transformed; Cell Survival; Cobalt; Enzyme Activation; Epithelial Cells; Gene Expression Regulation, Enzymologic; Humans; Hyperoxia; Oxygen; Promoter Regions, Genetic; Protein Processing, Post-Translational; Reperfusion Injury; Respiratory Mucosa; RNA, Messenger; Substrate Specificity; Transcription, Genetic; Xanthine Oxidase | 2003 |
VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism.
Topics: Animals; Cell Line; Cobalt; Cycloheximide; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Endothelial Growth Factors; Glucocorticoids; Hyperoxia; Hypoxia; Lymphokines; Mice; Nickel; Nucleic Acid Synthesis Inhibitors; Osteoblasts; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |